Effect of trivalent arsenicals on cell proliferation in mouse and human microvascular endothelial cells

Puttappa R. Dodmane, Lora L Arnold, Karen L. Pennington, Rakesh K Singh, Ana Paula Ferragut Cardoso, Samuel Monroe Cohen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Chronic exposure to high levels of inorganic arsenic (iAs) has been associated with cancerous and non-cancerous health effects, including cardiovascular effects. However, the mechanism for a presumed toxic effect of arsenic on vascular tissue is not clear. Our working hypothesis is that inorganic trivalent arsenic and its methylated metabolites react with cysteine-containing cellular proteins and alter their function leading to adverse events such as cytotoxicity or proliferation. In this study, human microvascular endothelial cells (HMEC1) and mouse microvascular endothelial cells (MFP-MVEC) were exposed to arsenite (iAs<sup>III</sup>), monomethylarsonous acid (MMA<sup>III</sup>), or dimethylarsinous acid (DMA<sup>III</sup>) for 72h to evaluate cytotoxicity, and for 24, 48 or 72h to evaluate cell proliferation. Both cell lines showed similar LC<inf>50</inf> values, from 0.1 to 2.4μM, for all three trivalent arsenicals. The endothelial cells treated with1nM to 1μM concentrations of the three trivalent arsenicals did not show increased cell proliferation at 24, 48 or 72h or increased rate of proliferation at 72h of exposure. Overall, cytotoxicity of trivalent arsenicals to microvascular endothelial cells is similar to their cytotoxicity to epithelial cells, and that these compounds are not mitogenic.

Original languageEnglish (US)
Pages (from-to)833-837
Number of pages5
JournalToxicology Reports
Volume2
DOIs
StatePublished - May 1 2015

Fingerprint

Arsenicals
Endothelial cells
Cell proliferation
Cytotoxicity
Arsenic
Endothelial Cells
Cell Proliferation
Poisons
Metabolites
Cysteine
Blood Vessels
Epithelial Cells
Cells
Health
Tissue
Cell Line
Proteins

Keywords

  • Arsenic
  • Cardiovascular
  • Cytotoxicity
  • Mitogenesis

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Toxicology

Cite this

Effect of trivalent arsenicals on cell proliferation in mouse and human microvascular endothelial cells. / Dodmane, Puttappa R.; Arnold, Lora L; Pennington, Karen L.; Singh, Rakesh K; Cardoso, Ana Paula Ferragut; Cohen, Samuel Monroe.

In: Toxicology Reports, Vol. 2, 01.05.2015, p. 833-837.

Research output: Contribution to journalArticle

@article{91ae1b6bace44d3281f8ff90f067e33e,
title = "Effect of trivalent arsenicals on cell proliferation in mouse and human microvascular endothelial cells",
abstract = "Chronic exposure to high levels of inorganic arsenic (iAs) has been associated with cancerous and non-cancerous health effects, including cardiovascular effects. However, the mechanism for a presumed toxic effect of arsenic on vascular tissue is not clear. Our working hypothesis is that inorganic trivalent arsenic and its methylated metabolites react with cysteine-containing cellular proteins and alter their function leading to adverse events such as cytotoxicity or proliferation. In this study, human microvascular endothelial cells (HMEC1) and mouse microvascular endothelial cells (MFP-MVEC) were exposed to arsenite (iAsIII), monomethylarsonous acid (MMAIII), or dimethylarsinous acid (DMAIII) for 72h to evaluate cytotoxicity, and for 24, 48 or 72h to evaluate cell proliferation. Both cell lines showed similar LC50 values, from 0.1 to 2.4μM, for all three trivalent arsenicals. The endothelial cells treated with1nM to 1μM concentrations of the three trivalent arsenicals did not show increased cell proliferation at 24, 48 or 72h or increased rate of proliferation at 72h of exposure. Overall, cytotoxicity of trivalent arsenicals to microvascular endothelial cells is similar to their cytotoxicity to epithelial cells, and that these compounds are not mitogenic.",
keywords = "Arsenic, Cardiovascular, Cytotoxicity, Mitogenesis",
author = "Dodmane, {Puttappa R.} and Arnold, {Lora L} and Pennington, {Karen L.} and Singh, {Rakesh K} and Cardoso, {Ana Paula Ferragut} and Cohen, {Samuel Monroe}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.toxrep.2015.05.009",
language = "English (US)",
volume = "2",
pages = "833--837",
journal = "Toxicology Reports",
issn = "2214-7500",
publisher = "Elsevier Scientific Publishers Ireland",

}

TY - JOUR

T1 - Effect of trivalent arsenicals on cell proliferation in mouse and human microvascular endothelial cells

AU - Dodmane, Puttappa R.

AU - Arnold, Lora L

AU - Pennington, Karen L.

AU - Singh, Rakesh K

AU - Cardoso, Ana Paula Ferragut

AU - Cohen, Samuel Monroe

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Chronic exposure to high levels of inorganic arsenic (iAs) has been associated with cancerous and non-cancerous health effects, including cardiovascular effects. However, the mechanism for a presumed toxic effect of arsenic on vascular tissue is not clear. Our working hypothesis is that inorganic trivalent arsenic and its methylated metabolites react with cysteine-containing cellular proteins and alter their function leading to adverse events such as cytotoxicity or proliferation. In this study, human microvascular endothelial cells (HMEC1) and mouse microvascular endothelial cells (MFP-MVEC) were exposed to arsenite (iAsIII), monomethylarsonous acid (MMAIII), or dimethylarsinous acid (DMAIII) for 72h to evaluate cytotoxicity, and for 24, 48 or 72h to evaluate cell proliferation. Both cell lines showed similar LC50 values, from 0.1 to 2.4μM, for all three trivalent arsenicals. The endothelial cells treated with1nM to 1μM concentrations of the three trivalent arsenicals did not show increased cell proliferation at 24, 48 or 72h or increased rate of proliferation at 72h of exposure. Overall, cytotoxicity of trivalent arsenicals to microvascular endothelial cells is similar to their cytotoxicity to epithelial cells, and that these compounds are not mitogenic.

AB - Chronic exposure to high levels of inorganic arsenic (iAs) has been associated with cancerous and non-cancerous health effects, including cardiovascular effects. However, the mechanism for a presumed toxic effect of arsenic on vascular tissue is not clear. Our working hypothesis is that inorganic trivalent arsenic and its methylated metabolites react with cysteine-containing cellular proteins and alter their function leading to adverse events such as cytotoxicity or proliferation. In this study, human microvascular endothelial cells (HMEC1) and mouse microvascular endothelial cells (MFP-MVEC) were exposed to arsenite (iAsIII), monomethylarsonous acid (MMAIII), or dimethylarsinous acid (DMAIII) for 72h to evaluate cytotoxicity, and for 24, 48 or 72h to evaluate cell proliferation. Both cell lines showed similar LC50 values, from 0.1 to 2.4μM, for all three trivalent arsenicals. The endothelial cells treated with1nM to 1μM concentrations of the three trivalent arsenicals did not show increased cell proliferation at 24, 48 or 72h or increased rate of proliferation at 72h of exposure. Overall, cytotoxicity of trivalent arsenicals to microvascular endothelial cells is similar to their cytotoxicity to epithelial cells, and that these compounds are not mitogenic.

KW - Arsenic

KW - Cardiovascular

KW - Cytotoxicity

KW - Mitogenesis

UR - http://www.scopus.com/inward/record.url?scp=84930937652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930937652&partnerID=8YFLogxK

U2 - 10.1016/j.toxrep.2015.05.009

DO - 10.1016/j.toxrep.2015.05.009

M3 - Article

VL - 2

SP - 833

EP - 837

JO - Toxicology Reports

JF - Toxicology Reports

SN - 2214-7500

ER -